Studies assessing fatty acid synthase [9,10], enoyl-CoA hydratase short-chain 1 (ECHS1) [11], HDL-Receptor SR-BI [12], the lipid transporter CD36 [13], FA catabolic enzymes [10,14] or the fatty acid transport protein 4 [15] suggest that these genes regulate ccRCC tumor growth and can predict patient survival. The gene discussed is ECHS1; the disease is nonpapillary renal cell carcinoma.